World's Best Scientists 2026 revealed!
Ludger Klein-Hitpass

Ludger Klein-Hitpass

D-Index & Metrics

Genetics

D-Index
64
Citations
13896
World Ranking
2801
National Ranking
199

Ludger Klein-Hitpass publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Ludger Klein-Hitpass sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 187 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Ludger Klein-Hitpass D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Ludger Klein-Hitpass sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 64 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Ludger Klein-Hitpass is affiliated with the University of Duisburg-Essen in Germany. Their research spans multiple fields within biomedical science, focusing primarily on Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology.

Their work covers a range of subfields, including Immunology, Molecular Biology, Genetics, Oncology, and Pulmonary and Respiratory Medicine. The main research topics addressed by Ludger Klein-Hitpass involve Immune Response and Inflammation, Epigenetics and DNA Methylation, Identity, Memory, and Therapy, Chronic Lymphocytic Leukemia Research, Glioma Diagnosis and Treatment, Advanced Electron Microscopy Techniques and Applications, and Sarcoma Diagnosis and Treatment.

Frequent coauthors in their publications include Ulrich Dührsen, Patricia Johansson, Bettina Budeus, Jan Dürig, and Inken Wohlers. These collaborations appear consistently across their recent scientific contributions.

Notable recent papers authored or coauthored by Ludger Klein-Hitpass include:

  • CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort (2020, Acta Neuropathologica)
  • Acute myeloid leukemia-induced remodeling of the human bone marrow niche predicts clinical outcome (2020, Blood Advances)
  • Targeted bisulfite sequencing: A novel tool for the assessment of DNA methylation with high sensitivity and increased coverage (2020, Psychoneuroendocrinology)
  • Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing (2020, Cancers)
  • Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia (2020, Therapeutic Advances in Hematology)

Their publications have appeared frequently in journals such as Frontiers in Immunology, Acta Neuropathologica, Blood Advances, Psychoneuroendocrinology, and Cancers, demonstrating interdisciplinary reach within clinical and molecular biomedical research.

Best Publications

  • An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells.

    L Klein-Hitpass;M Schorpp;U Wagner;G U Ryffel

  • A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor

    Ludger Klein-Hitpass;Gerhart U. Ryffel;Ellen Heitlinger;Andrew C.B. Cato

  • Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.

    Marcel Martin;Marcel Martin;Lars Maßhöfer;Petra Temming;Sven Rahmann

  • Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

    Johannes H. Schulte;Soyoung Lim;Alexander Schramm;Nicolaus Friedrichs

  • LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression

    Jan J Molenaar;Raquel Domingo-Fernández;Marli E Ebus;Sven Lindner

  • Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells

    Hui Zeng;Raif Yücel;Christian Kosan;Ludger Klein‐Hitpass

  • ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia

    J Dürig;H Nückel;M Cremer;A Führer

  • MYCN regulates oncogenic MicroRNAs in neuroblastoma.

    Johannes H. Schulte;Sebastian Horn;Tobias Otto;Birgit Samans

  • The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element.

    Jurgen Behrens;Oliver Lowrick;Ludger Klein-Hitpass;Walter Birchmeier

  • Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

    R Schroers;F Griesinger;L Trümper;D Haase

  • The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex.

    Ludger Klein-Hitpass;Sophia Y. Tsai;Nancy L. Weigel;George F. Allan

  • A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling.

    Dagmar Wieczorek;Nina Bögershausen;Filippo Beleggia;Sabine Steiner-Haldenstätt

  • Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.

    Antje Sucker;Fang Zhao;Natalia Pieper;Christina Heeke

  • The Transcriptional Profile of Mesenchymal Stem Cell Populations in Primary Osteoporosis Is Distinct and Shows Overexpression of Osteogenic Inhibitors

    Peggy Benisch;Tatjana Schilling;Ludger Klein-Hitpass;Sönke P. Frey

  • Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells

    Ludger Klein-Hitpass;Andrew C.B. Cato;David Henderson;Gerhart U. Ryffel

  • Uncovering the cellular and molecular changes in tendon stem/progenitor cells attributed to tendon aging and degeneration

    Julia Kohler;Cvetan Popov;Barbara Klotz;Paolo Alberton

  • Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo

    Gloria Lutzny;Thomas Kocher;Marc Schmidt-Supprian;Martina Rudelius

  • Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.

    M. Woenckhaus;L. Klein-Hitpass;U. Grepmeier;J. Merk

  • The Transcriptional Repressor Gfi1 Affects Development of Early, Uncommitted c-Kit+ T Cell Progenitors and CD4/CD8 Lineage Decision in the Thymus

    Raif Yücel;Holger Karsunky;Ludger Klein-Hitpass;Tarik Möröy

  • Connexin43 Interacts with NOV A POSSIBLE MECHANISM FOR NEGATIVE REGULATION OF CELL GROWTH IN CHORIOCARCINOMA CELLS

    Alexandra Gellhaus;Xuesen Dong;Sven Propson;Karen Maass

Frequent Co-Authors

Ulrich Dührsen
Ulrich Dührsen University of Duisburg-Essen
Gerhart U. Ryffel
Gerhart U. Ryffel University of Duisburg-Essen
Bernhard Horsthemke
Bernhard Horsthemke University of Duisburg-Essen
Ralf Küppers
Ralf Küppers University of Duisburg-Essen
Johannes H. Schulte
Johannes H. Schulte Charité - University Medicine Berlin
Tarik Möröy
Tarik Möröy University of Montreal
Reiner Siebert
Reiner Siebert University of Ulm
Benedikt Brors
Benedikt Brors German Cancer Research Center
Gerd Schmitz
Gerd Schmitz University of Regensburg
Philip Rosenstiel
Philip Rosenstiel Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in Genetics can lead to diverse careers beyond traditional research roles. Many students choose flexible online programs to accelerate their studies or transition into healthcare professions. For those looking to build on existing nursing qualifications, rn to bsn online programs offer a convenient, clinical-free pathway to advance their knowledge and career prospects.

Students pursuing advanced leadership may consider a fastest bsn to dnp program, which can provide doctoral-level expertise in a condensed timeframe. For individuals seeking a quicker entry into healthcare, enrolling in an accelerated cma program might be an ideal option—some programs can be completed in just six weeks.

For those interested in clinical practice and research, a dnp degree offers advanced clinical training and leadership opportunities. With genetics becoming increasingly important in personalized medicine, choosing the right degree pathway can help you stand out in today’s job market.

Best Scientists Citing Ludger Klein-Hitpass

Trending Scientists

Recently Published Articles